A Trial of MitoQ for the Treatment of People With Parkinson's Disease

NCT00329056 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: MitoQ

Sponsor

Antipodean Pharmaceuticals, Inc.